A reliable tool for detecting 7‐dehydrocholesterol and cholesterol in human plasma and its use in diagnosis of Smith–Lemli–Opitz syndrome
- 28 December 2021
- journal article
- research article
- Published by Wiley in Journal of Separation Science
- Vol. 45 (5) , 1080-1093
Abstract
Background: Smith–Lemli–Opitz syndrome is a birth defect caused by the deficiency of 7‐dehydrocholesterol reductase in cholesterol biosynthesis pathway, which leads to accumulation of 7‐dehydrocholesterol and reduction of cholesterol in body fluids. To effectively diagnose Smith–Lemli–Opitz syndrome and monitor therapy, a reliable method for simultaneous detection of 7‐dehydrocholesterol and cholesterol is needed.Methods: In the presence of antioxidants (2,6‐ditert‐butyl‐4‐methylphenol and triphenylphosphine), 50 μL of human plasma were hydrolyzed at 70℃ for 40 min with 1 M potassium hydroxide in 90% ethanol, and then 7‐dehydrocholesterol and cholesterol were extracted by 600 μL of n‐hexane for three times. After microwave‐assisted derivatization with 70 μL of N,O‐bis(trimethylsilyl)trifluoroacetamide at 460 W for 3 min, the analytes were measured by gas chromatography‐mass spectrometry.Results: The limits of detection were 100 ng/mL for 7‐dehydrocholesterol and 300 ng/mL for cholesterol. Good linearity was obtained in the range of 1–600 μg/mL for 7‐dehydrocholesterol and 10–600 μg/mL for cholesterol, which completely covered the biochemical levels of Smith–Lemli–Opitz syndrome patients that have been reported.Conclusion: A time‐saving and accurate gas chromatography with mass spectrometry based method was developed for the determination of 7‐dehydrocholesterol and cholesterol in human plasma, which also serves as a useful tool for Smith–Lemli–Opitz syndrome diagnosis, treatment, and research.Keywords
This publication has 47 references indexed in Scilit:
- A routine method for cholesterol and 7-dehydrocholesterol analysis in dried blood spot by GC–FID to diagnose the Smith–Lemli–Opitz syndromeJournal of Chromatography B, 2012
- Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndromeJournal of Lipid Research, 2010
- Hair and skin sterols in normal mice and those with deficient dehydrosterol reductase (DHCR7), the enzyme associated with Smith-Lemli-Opitz syndromeThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Discordant phenotype and sterol biochemistry in Smith–Lemli–Opitz syndromeAmerican Journal of Medical Genetics Part A, 2010
- Ex Vivo Oxidation in Tissue and Plasma Assays of Hydroxyoctadecadienoates: Z,E/E,E Stereoisomer RatiosChemical Research in Toxicology, 2010
- Oxysterols from Free Radical Chain Oxidation of 7-Dehydrocholesterol: Product and Mechanistic StudiesJournal of the American Chemical Society, 2010
- Rate Constants for Peroxidation of Polyunsaturated Fatty Acids and Sterols in Solution and in LiposomesJournal of the American Chemical Society, 2009
- Gas chromatographic-mass spectrometric analyses of cholesterol and its precursors in rat plasma as tert-butyldimethylsilyl derivativesClinica Chimica Acta, 2008
- DHCR7 mutation carrier rates and prevalence of the RSH/Smith‐Lemli‐Opitz syndrome: Where are the patients?American Journal of Medical Genetics Part A, 2006
- Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndromeThe Journal of Pediatrics, 1995